Ester Lozano

3.3k total citations · 1 hit paper
43 papers, 2.5k citations indexed

About

Ester Lozano is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Ester Lozano has authored 43 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 13 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in Ester Lozano's work include Multiple Myeloma Research and Treatments (13 papers), Vasculitis and related conditions (12 papers) and Immune Cell Function and Interaction (9 papers). Ester Lozano is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Vasculitis and related conditions (12 papers) and Immune Cell Function and Interaction (9 papers). Ester Lozano collaborates with scholars based in Spain, United States and Switzerland. Ester Lozano's co-authors include Vijay K. Kuchroo, David A. Hafler, María C. Cid, Margarita Dominguez‐Villar, José Hernández‐Rodríguez, Marta Segarra, Nicole Joller, Ana García‐Martínez, Georgina Espígol‐Frigolé and Chen Zhu and has published in prestigious journals such as Blood, Immunity and The Journal of Immunology.

In The Last Decade

Ester Lozano

40 papers receiving 2.5k citations

Hit Papers

Treg Cells Expressing the Coinhibitory Molecule TIGIT Sel... 2014 2026 2018 2022 2014 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
    2014 714 citations Ester Lozano et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Lozano Spain 23 1.5k 778 659 509 393 43 2.5k
Stefan Kuchen Switzerland 24 1.7k 1.1× 528 0.7× 416 0.6× 855 1.7× 903 2.3× 35 3.2k
Ingrid Durand–Gasselin France 27 1.5k 1.0× 985 1.3× 823 1.2× 352 0.7× 436 1.1× 41 3.1k
Ulf Panzer Germany 30 1.7k 1.2× 578 0.7× 346 0.5× 438 0.9× 380 1.0× 53 3.0k
Tomonori Ishii Japan 28 747 0.5× 690 0.9× 428 0.6× 864 1.7× 640 1.6× 153 2.8k
Hirofumi Shoda Japan 23 1.1k 0.8× 211 0.3× 432 0.7× 515 1.0× 450 1.1× 100 2.0k
Kazuhiro Kurasawa Japan 26 1.1k 0.8× 435 0.6× 207 0.3× 692 1.4× 359 0.9× 81 2.4k
A Portier France 20 968 0.7× 882 1.1× 469 0.7× 220 0.4× 445 1.1× 42 2.4k
Christof Iking‐Konert Germany 23 811 0.6× 333 0.4× 148 0.2× 531 1.0× 282 0.7× 67 1.8k
Mitsuteru Akahoshi Japan 26 1.4k 0.9× 241 0.3× 291 0.4× 784 1.5× 365 0.9× 68 2.3k
Hajime Yoshifuji Japan 26 743 0.5× 579 0.7× 234 0.4× 1.2k 2.3× 415 1.1× 146 2.4k

Countries citing papers authored by Ester Lozano

Since Specialization
Citations

This map shows the geographic impact of Ester Lozano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Lozano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Lozano more than expected).

Fields of papers citing papers by Ester Lozano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Lozano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Lozano. The network helps show where Ester Lozano may publish in the future.

Co-authorship network of co-authors of Ester Lozano

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Lozano. A scholar is included among the top collaborators of Ester Lozano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Lozano. Ester Lozano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guitart‐Mampel, Mariona, Francesc Josep García‐García, Ester Tobías, et al.. (2024). Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV. International Journal of Molecular Sciences. 25(15). 8418–8418.
2.
Rodríguez‐Lobato, Luis Gerardo, Natalia Tovar, María Teresa Cibeira, et al.. (2024). The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma. HemaSphere. 8(5). e76–e76. 3 indexed citations
3.
Lozano, Ester, Mari-Pau Mena, Glòria Garrabou, et al.. (2024). Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma. Clinical Cancer Research. 30(17). 3944–3955.
4.
Morén, Constanza, Francesc Josep García‐García, Alberto Blázquez, et al.. (2022). Multicentric Standardization of Protocols for the Diagnosis of Human Mitochondrial Respiratory Chain Defects. Antioxidants. 11(4). 741–741. 5 indexed citations
5.
Grau, Josep M., et al.. (2021). Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency. Journal of Clinical Medicine. 10(16). 3471–3471. 3 indexed citations
6.
Lozano, Ester, Mari-Pau Mena, Tania Díaz, et al.. (2020). Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma. Clinical Cancer Research. 26(17). 4688–4698. 38 indexed citations
7.
Rosal‐Vela, Antonio, Ismael Sánchez-Gomar, Margarita Jiménez-Palomares, et al.. (2020). Molecular signatures of atherosclerotic plaques: An up-dated panel of protein related markers. Journal of Proteomics. 221. 103757–103757. 13 indexed citations
8.
Martín-Antonio, Beatriz, Guillermo Suñé, Lorena Pérez-Amill, et al.. (2019). Extracellular NK histones promote immune cell anti-tumor activity by inducing cell clusters through binding to CD138 receptor. Journal for ImmunoTherapy of Cancer. 7(1). 259–259. 16 indexed citations
9.
Espígol‐Frigolé, Georgina, Ester Planas‐Rigol, Ester Lozano, et al.. (2018). Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways. Frontiers in Immunology. 9. 809–809. 36 indexed citations
10.
Larrea, Carlos Fernández de, Arturo Pereira, Ma Teresa Cibeira, et al.. (2018). Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression. Leukemia. 32(6). 1427–1434. 36 indexed citations
11.
Rodríguez‐Lobato, Luis Gerardo, Carlos Fernández de Larrea, María Teresa Cibeira, et al.. (2017). Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis. Amyloid. 24(4). 238–245. 4 indexed citations
12.
Corbera‐Bellalta, Marc, Ester Planas‐Rigol, Ester Lozano, et al.. (2015). Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis. Annals of the Rheumatic Diseases. 75(6). 1177–1186. 95 indexed citations
13.
Corbera‐Bellalta, Marc, Ana García‐Martínez, Ester Lozano, et al.. (2013). Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis. Annals of the Rheumatic Diseases. 73(3). 616–623. 54 indexed citations
14.
Espígol‐Frigolé, Georgina, Marc Corbera‐Bellalta, Ester Planas‐Rigol, et al.. (2012). Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis. Annals of the Rheumatic Diseases. 72(9). 1481–1487. 77 indexed citations
15.
Visvanathan, Sudha, Mahboob U. Rahman, Gary S. Hoffman, et al.. (2011). Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal study. Lara D. Veeken. 50(11). 2061–2070. 84 indexed citations
16.
García‐Martínez, Ana, José Hernández‐Rodríguez, Georgina Espígol‐Frigolé, et al.. (2010). Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin‐6) in the long‐term followup of patients with giant cell arteritis. Arthritis Care & Research. 62(6). 835–841. 70 indexed citations
17.
Lozano, Ester, Marta Segarra, Marc Corbera‐Bellalta, et al.. (2009). Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events. Annals of the Rheumatic Diseases. 69(2). 434–442. 47 indexed citations
18.
Segarra, Marta, Ester Lozano, Marc Corbera‐Bellalta, et al.. (2009). Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways. Haematologica. 95(3). 456–463. 14 indexed citations
19.
Cibeira, María Teresa, Marı́a Rozman, Marta Segarra, et al.. (2008). Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents. Cytokine. 41(3). 244–253. 22 indexed citations
20.
Cid, María C., Ana García‐Martínez, Ester Lozano, Georgina Espígol‐Frigolé, & José Hernández‐Rodríguez. (2007). Five Clinical Conundrums in the Management of Giant Cell Arteritis. Rheumatic Disease Clinics of North America. 33(4). 819–834. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Kuchen Breakdown of academic impact, for papers by Ingrid Durand–Gasselin Breakdown of academic impact, for papers by Ulf Panzer Breakdown of academic impact, for papers by Tomonori Ishii Breakdown of academic impact, for papers by Hirofumi Shoda Breakdown of academic impact, for papers by Kazuhiro Kurasawa Breakdown of academic impact, for papers by A Portier Breakdown of academic impact, for papers by Christof Iking‐Konert Breakdown of academic impact, for papers by Mitsuteru Akahoshi Breakdown of academic impact, for papers by Hajime Yoshifuji
Rankless by CCL
2026